SCHEMBL5073571

SCHEMBL5073571

COc1ccc(C(=C(C)C#N)c2ccc(OC)c(OC)c2)cc1OC

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.56
CYP1A2 P05177 1/20 0.56
CYP3A4 P08684 1/20 0.56
CYP2C9 P11712 1/20 0.56
CYP2C19 P33261 1/20 0.56
PDE4A P27815 8/20 0.56
PDE4B Q07343 8/20 0.56
PDE4C Q08493 8/20 0.56
PDE4D Q08499 8/20 0.56
CA12 O43570 1/20 0.55
CA1 P00915 1/20 0.55
CA2 P00918 1/20 0.55
CA4 P22748 1/20 0.55
CA6 P23280 1/20 0.55
CA7 P43166 1/20 0.55
TPMT P51580 1/20 0.55
CA9 Q16790 1/20 0.55
CA14 Q9ULX7 1/20 0.55
HPGD P15428 1/20 0.54
MAPT P10636 4/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30413049 0.80 CYP1A2 (0.63) TSHRCYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL976684 0.80 CYP1A2 (0.63) TSHRCYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL7222765 0.79 PDE4B (0.61) TSHRCYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL11823844 0.79 PDE4A (0.56) TSHRCYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL1981893 0.79 HPGD (0.57) TSHRCYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL28217401 0.76 HPGD (0.69) TSHRCYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL4570677 0.76 NPSR1 (0.52) TSHRCYP1A2CYP3A4CYP2C19PDE4A
SCHEMBL29399077 0.75 TSHR (0.73) TSHRCYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL76834 0.75 TSHR (0.73) TSHRCYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL27753902 0.75 TSHR (0.73) TSHRCYP1A2CYP3A4CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1361210-B1 Novel immunotherapeutic agents and their use in the reduction of cytokine levels CELGENE CORP (US) 2008-12-24 EP disclosed